CYP1B1 and breast cancer: Compared with the wild-type genotypes of CYP1B1 rs1056836 (GG), the heterozygous variant genotypes significantly reduced the risk of breast cancer, yielding an OR of 0.37 (95% CI = 0.21–0.67).